Correlation of TGF-(Si Expression with Medroxiprogesterone Acetate Responsiveness in Mouse Mammary Adenocarcinomas

References

• Lippman M E, Dickson R B. Mechanisms of normal and malignant breast epithelial growth regulation. J Steroid Biochem 1989; 34: 107–121
   PubMedGoogle Scholar
• Lippman M E, Dickson R B. Mechanisms of growth control in normal and malignant breast epithelium. Recent Progress in Hormone Research, J H Clark. Academic Press, New York 1989; 383–440
   Google Scholar
• Cullen K J, Lippman M E. Estrogen regulation of protein synthesis and cell growth in human breast cancer. Vitamins and Hormones, G D Aurbach, D B McCormick. Academic Press, New York 1989; 127–172
   Google Scholar
• Bergkvist L, Adami H-O, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321: 293–297
   PubMed Web of Science ®Google Scholar
• Murphy L C, Dotzlaw H. Regulation of transforming growth factor α and transforming growth factor β messenger ribonucleic acid abundance in T-47D. human breast cancer cells. Mol Endocrinol 1989; 3: 611–617
   PubMed Web of Science ®Google Scholar
• Lanari C, Molinolo A A, Dosne Pasqualini C. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett 1986; 33: 215–223
   PubMed Web of Science ®Google Scholar
• Molinolo A A, Lanari C, Charreau E H, et al. Mouse mammary tumors induced by medroxyprogesterone acetate: lm-munochemistry and hormonal receptors. J Natl Cancer Inst 1987; 79: 1341–1350
   PubMed Web of Science ®Google Scholar
• Lanari C, Kordon E, Molinolo A A, et al. Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and EOF receptors of BALB/c in vivo sublines. Int J Cancer 1989; 43: 845–850
   PubMed Web of Science ®Google Scholar
• Elizalde P V, Lanari C, Kordon E, et al. Transforming growth factor-β activities in “in vivo” lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice. Breast Cancer Res Treat 1990; 16: 29–39
   PubMed Web of Science ®Google Scholar
• Miller D A, Pelton R W, Derynk R, et al. Transforming growth factor-0: A family of growth regulatory peptides. Ann NY Acad Sci 1990; 593: 208–217
   PubMed Web of Science ®Google Scholar
• Roberts A B, Sporn M B. The transforming growth factors. Handbook of Experimental Pharmacology, M B Sporn, A B Roberts. Springer-Verlag, Heidelberg 1990; 419–472
   Google Scholar
• Bascom C C, Sipes N J, Coffey R J, et al. Regulation of cell proliferation by transforming growth factors. J Cell Biochem 1989; 39: 25–32
   PubMed Web of Science ®Google Scholar
• Lyons R M, Moses H L. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990; 187: 467–473
   PubMedGoogle Scholar
• Bronzert D A, Bates S E, Sheridan L P, et al. Transforming growth factor-β induces platelet derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells. Mol Endocrinol 1990; 4: 981–989
   PubMed Web of Science ®Google Scholar
• Valverius E M, Walker-Jones D, Bates S E, et al. Production and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res 1989; 49: 6269–6274
   PubMed Web of Science ®Google Scholar
• Zugmaier G, Ennis B W, Deschauer B, et al. Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol 1989; 141: 353–361
   PubMed Web of Science ®Google Scholar
• Heifetz S, Weatherbee J A, Tsang M L-S, et al. The transforming growth-β-system, a complex pattern of cross reactive ligands and receptors. Cell 1987; 48: 409–415
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Massague J. The TGF-β receptor proteoglycan. Cell surface expression and ligand in the absence of glyco-saminoglycan chains. J Biol Chem 1989; 264: 12025–12028
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Ling N, Guillemin R, et al. A surface component on GH3 pituitary cells that recognizes transforming growth factor-0, activin, and inhibin. J Biol Chem 1989; 263: 17225–17228
   Web of Science ®Google Scholar
• O'Grady P, Kuo M-D, Baldassare J J, et al. Purification of a new type of high molecular weight receptor (type V receptor) of transforming growth factor β(TGF-β) from bovine liver. J Biol Chem 1991; 266: 8583–8589
   PubMed Web of Science ®Google Scholar
• Boyd F T, Massagué J. Transforming growth factor /3 inhibition of epithelial cell proliferation linked to the expression of a 53 kDa membrane receptor. J Biol Chem 1989; 264: 2272–2278
   PubMed Web of Science ®Google Scholar
• Clarke R, Brunner N, Katz D, et al. The effects of a constitutive expression of transforming growth factor-a on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol Endocrinol 1989; 3: 372–380
   PubMed Web of Science ®Google Scholar
• Chirgwin J, Pryzbyla A, McDonald R, et al. Isolation of biologically active ribonucleic acid from sources enriched for ribonuclease. Biochemistry 1979; 18: 5294–5298
   PubMed Web of Science ®Google Scholar
• Frolik C A, Wakefield L M, Smith D M, et al. Characterization of a membrane receptor for transforming growth factor-j3 in normal rat kidney fibroblasts. J Biol Chem 1984; 259: 10995–11000
   PubMed Web of Science ®Google Scholar
• Massagué J, Like B. Cellular receptors for type βtransforming growth factor. J Biol Chem 1985; 260: 2636–2645
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attraction of proteins from small molecules and ions. Ann NY Acad Sci 1949; 51: 660–672
   Web of Science ®Google Scholar
• Knabbe C, Lippman M E, Wakefield L M, et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–428
   PubMed Web of Science ®Google Scholar
• Arteaga C L, Tandom A K, Von Hoff D D, et al. Transforming growth factor β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 1988; 48: 3898–3904
   PubMed Web of Science ®Google Scholar
• Clarke C L, Sutherland R L. Progestin regulation of cellular proliferation. Endocrinol Rev 1990; 11: 266–301
   PubMed Web of Science ®Google Scholar
• Colletta A A, Wakefield L M, Howell F V, et al. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor /3. J Clin Invest 1991; 87: 277–283
   PubMed Web of Science ®Google Scholar
• Jeng M-H, Jordan V C. Growth stimulation and differential regulationof transforming growth factor-β1 (TGF-β1) TGF-β2 and TGFβ3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Mol Endocrinol 1991; 5: 1120–1128
   PubMed Web of Science ®Google Scholar
• Arryck B A, Korc M, Derynk R. Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol. Cancer Res 1990; 50: 299–303
   PubMed Web of Science ®Google Scholar
• Dickson R B, Huff K K, Spencer E M, et al. Induction of epidermal growth factor-related polypeptides by 17β-estradiol in MCF-7 cells. Endocrinology 1986; 188: 138–142
   Google Scholar
• Valverius E M, Bates S E, Stampfer M R, et al. Transforming growth factor α production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol Endocrinol 1989; 3: 203–214
   PubMed Web of Science ®Google Scholar
• Derynk R, Goeddel D V, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Bates S E, Davidson S E, Valverius E M, et al. Expression of transforming growth factor alpha and its mRNA in human breast cancer: Its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988; 2: 543–555
   PubMed Web of Science ®Google Scholar
• Dickson R B, McManaway M E, Lippman M E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 1986; 232: 1540–1543
   PubMed Web of Science ®Google Scholar
• Salomon D S, Perroteau I, Kidwell W R, et al. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras transformed mouse mammary epithelial cells. J Cell Physiol 1987; 130: 397–409
   PubMed Web of Science ®Google Scholar
• Liu S C, Sannfilippo B, Perroteau I, et al. Expression of transforming growth factor α (TGF-α) in differentiated rat mammary tumors: Estrogen induction of TGF production. Mol Endocrinol 1987; 1: 683–692
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Kim N, Liscia D S, et al. mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients. J Natl Cancer Inst 1989; 81: 1165–1171
   PubMed Web of Science ®Google Scholar
• Murphy L C, Dotzlaw H. Endogenous growth factor expression in T-47D. human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and anti-estrogens. Cance Res 1989; 49: 599–604
   PubMed Web of Science ®Google Scholar
• Sutherland R L, Lee C. S.L, Healey P RJ, et al. Progestin and glucocorticoid regulation of epidermal growth factor receptor and alpha transforming growth factor gene expression in human breast cancer cells. Am Assoc Cancer Res 1989; 30: 261, (abstract)
   Google Scholar